1. 138: Prescribing Long-Term Asthma Controller in Poorly Controlled Children with Persistent Asthma: Reported Behaviour, Facilitators and Solutions. Issue 5 (1st June 2015) Authors: Ducharme, F; Lamontagne, AJ; Pelaez, S; Grad, R; Lavoie, K; Ernst, P; McKinney, ML; Bacon, S; Guay, H; Collin, J; Blais, L Journal: Paediatrics & Child Health Issue: Volume 20:Issue 5(2015) Page Start: e84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP79 Biomarkers for IBD using OLINK Proteomics inflammation panel: Preliminary results from the COLLIBRI consortium. (21st January 2022) Authors: Sudhakar, P; Salomon, B; Verstockt, B; Ungaro, R; Aden, K; D'Haens, G; Komori, K; Guay, H; Silverberg, M; Vermeire, S; Halfvarson, J Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP81 Baseline whole-blood gene expression of TREM1 does not predict clinical or endoscopic outcomes following adalimumab treatment in patients with Ulcerative Colitis or Crohn's Disease in the SERENE studies. (21st January 2022) Authors: Verstockt, B; Al Mahi, N; Pivorunas, V; Smaoui, N; Guay, H; Kennedy, N A; Hanauer, S B; Ferrante, M; Panés, J; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DOP88 Understanding the molecular mechanisms of anti-TNF treatment failure: Whole blood DNA methylation changes associated with primary non-response to anti-TNF treatment in patients with Crohn's disease. (30th January 2023) Authors: Lin, S; Hannon, E; Waring, J F; Reppell, M; Smaoui, N; Pivorunas, V L; Guay, H; Chanchlani, N; Bewshea, C; Bai, B Y H; Kennedy, N A; Goodhand, J R; Mill, J; Ahmad, T Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP30 Upadacitinib modulates inflammatory pathways in gut tissue in patients with Ulcerative Colitis: Transcriptomic profiling from the Phase 2b study, U-ACHIEVE. (21st January 2022) Authors: Verstockt, B; Blink Polakow, S; Mahi, N; Lee, J; Wang, J; Guay, H; Salas, A; Panés, J; Ungaro, R C; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i033 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P746 Identification of Altered Microbial Genera at Baseline in Adalimumab Clinical Remitters and an Absence of Change in Total Microbial Composition Post Induction Treatment in the SERENE UC Study. (30th January 2023) Authors: Morsy, Y; Pivorunas, V; Leitner, C; Birchler, T; Guay, H; Scharl, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i876 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗